Insider Trading Alert - CARA, MA And MPO Traded By Insiders

Yesterday, Jan. 27, 2016, 30 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $999.60 to $14,067,468.67.

Highlighted Stocks Traded by Insiders:

Cara Therapeutics (CARA) - FREE Research Report

Lewis Michael E, who is Chief Scientific Advisor at Cara Therapeutics, sold 7,262 shares at $10.93 on Jan. 27, 2016. Following this transaction, the Chief Scientific Advisor owned 314,988 shares meaning that the stake was reduced by 2.25% with the 7,262-share transaction.

The shares most recently traded at $9.74, down $1.19, or 12.22% since the insider transaction. Historical insider transactions for Cara Therapeutics go as follows:

  • 4-Week # shares bought: 3,000
  • 4-Week # shares sold: 18,500
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 24,500
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 43,500

The average volume for Cara Therapeutics has been 338,000 shares per day over the past 30 days. Cara Therapeutics has a market cap of $294.9 million and is part of the health care sector and drugs industry. Shares are down 35.77% year-to-date as of the close of trading on Wednesday.

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Currently, there are 4 analysts who rate Cara Therapeutics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CARA - FREE

TheStreet Quant Ratings rates Cara Therapeutics as a sell. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow and feeble growth in its earnings per share. Get the full Cara Therapeutics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

MasterCard (MA) - FREE Research Report

MasterCard Foundation, who is 10% Owner at MasterCard, sold 161,775 shares at $86.96 on Jan. 27, 2016. Following this transaction, the 10% Owner owned 115.8 million shares meaning that the stake was reduced by 0.14% with the 161,775-share transaction.

The shares most recently traded at $84.39, down $2.57, or 3.04% since the insider transaction. Historical insider transactions for MasterCard go as follows:

  • 4-Week # shares sold: 323,550
  • 12-Week # shares sold: 336,799
  • 24-Week # shares sold: 430,754

The average volume for MasterCard has been 4.3 million shares per day over the past 30 days. MasterCard has a market cap of $95.7 billion and is part of the financial sector and financial services industry. Shares are down 10.64% year-to-date as of the close of trading on Wednesday.

MasterCard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. The stock currently has a dividend yield of 0.88%. The company has a P/E ratio of 26.5. Currently, there are 20 analysts who rate MasterCard a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MA - FREE

TheStreet Quant Ratings rates MasterCard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full MasterCard Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Midstates Petroleum (MPO) - FREE Research Report

R/C IV Eagle Holdings, L.P., who is 10% Owner at Midstates Petroleum, sold 27,384 shares at $0.69 on Jan. 27, 2016. Following this transaction, the 10% Owner owned 2.6 million shares meaning that the stake was reduced by 1.04% with the 27,384-share transaction.

The shares most recently traded at $0.77, up $0.08, or 10.27% since the insider transaction. Historical insider transactions for Midstates Petroleum go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 305,655
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 400,302
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 914,979

The average volume for Midstates Petroleum has been 139,400 shares per day over the past 30 days. Midstates Petroleum has a market cap of $7.4 million and is part of the basic materials sector and energy industry. Shares are down 66.4% year-to-date as of the close of trading on Wednesday.

Midstates Petroleum Company, Inc. engages in the exploration, development, and production of oil, natural gas liquids, and natural gas in the United States. Currently, there is 1 analyst who rates Midstates Petroleum a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MPO - FREE

TheStreet Quant Ratings rates Midstates Petroleum as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Midstates Petroleum Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Stocks End Mixed as China Trade Progress Offsets D.C. Dysfunction

Stocks End Mixed as China Trade Progress Offsets D.C. Dysfunction

Market Madness: This Market Is for Stock Pickers

Market Madness: This Market Is for Stock Pickers

Jim Cramer: The Operative Term for This Tape Is Treacherous

Jim Cramer: The Operative Term for This Tape Is Treacherous

What Is Diffusion of Innovation and Why Is It Important in 2019?

What Is Diffusion of Innovation and Why Is It Important in 2019?

Striking Options: Tremendous Volatility, Energy, and Equities

Striking Options: Tremendous Volatility, Energy, and Equities